No Data
No Data
Yongtai Technology (002326.SZ): Net profit of 19.5056 million yuan in the first quarter decreased by 22.91% year-on-year
Gelonghui, April 25 | Yongtai Technology (002326.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 822 million yuan, down 18.31% year on year; net profit attributable to shareholders of listed companies was 19.5056 million yuan, down 22.91% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 143.116 million yuan, up 49.90% year on year; basic earnings per share were 0.021 yuan.
Zheshang Securities: The liquid cooling industry accelerates the promotion of fluorinated liquids in a new blue ocean
Compared with other types of coolants, fluorinated liquid has better comprehensive properties and is an ideal liquid cooling material.
Yongtai Technology (002326.SZ): Ningde Times holds 25% of Yongtai Hi-Tech's shares
Gelonghui March 22丨Yongtai Technology (002326.SZ) said on the investor interactive platform that Ningde Times holds 25% of Yongtai Hi-Tech's shares.
Yongtai Technology expects to lose more than 400 million dollars in 2023, and a lawsuit attracted attention
“Investor Network” Zhang Wei enters 2024, and domestic NEV companies are fiercely fighting a price war. The main reason has a lot to do with the “dive” in lithium battery prices in 2023. However, there are always two sides to the matter. The price reduction of lithium battery materials has given new energy vehicle companies the motivation to wage a price war, but it has also made many lithium companies feel pressured. Fluorine chemicals manufacturer Yongtai Technology (002326.SZ) is one of them. On January 30, Yongtai Technology released a performance forecast. It is estimated that net profit due to mother in 2023 will be a loss of 450 million yuan to 650 million yuan, a serious decrease from the 2022 profit of 554 million yuan. Eita
Yongtai Technology (002326.SZ): Currently actively promoting the development of products related to fluorinated liquids
Gelonghui, March 8 | Yongtai Technology (002326.SZ) said on the investor interactive platform that currently the company is actively promoting the development, process verification, and marketing of products related to fluorinated liquid to meet the needs of the downstream market.
Yongtai Technology's Fenofibrate Capsules Get US FDA Nod
Zhejiang Yongtai Technology's (SHE:002326) unit, Yongtai Technology (USA), received approval from the US Food and Drug Administration for fenofibrate capsules. The drug is mainly used for the treatmen
No Data